Qurient acquires patent of Quinolinyloxyphenylsulfonamides related to cancer treatment

Published: 2017-07-14 16:26:00
Updated: 2017-07-14 10:44:00

Qurient gave an official notice on the 12th that it acquired a patent of Quinolinyloxyphenylsulfonamides related to cancer treatment.

According to the company, the patent is about the core chemical structure of the anticancer immunity/resistance study and the use of its compound.(patentee: Max P...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean





TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.